These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1374843)

  • 1. The effect of orientation of epitopes on the immunogenicity of chimeric synthetic peptides representing measles virus protein sequences.
    Partidos C; Stanley C; Steward M
    Mol Immunol; 1992 May; 29(5):651-8. PubMed ID: 1374843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of orientation and number of copies of T and B cell epitopes on the specificity and affinity of antibodies induced by chimeric peptides.
    Partidos C; Stanley C; Steward M
    Eur J Immunol; 1992 Oct; 22(10):2675-80. PubMed ID: 1382995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune responses in mice following immunization with chimeric synthetic peptides representing B and T cell epitopes of measles virus proteins.
    Partidos CD; Stanley CM; Steward MW
    J Gen Virol; 1991 Jun; 72 ( Pt 6)():1293-9. PubMed ID: 1710646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection against morbillivirus-induced encephalitis by immunization with a rationally designed synthetic peptide vaccine containing B- and T-cell epitopes from the fusion protein of measles virus.
    Obeid OE; Partidos CD; Howard CR; Steward MW
    J Virol; 1995 Mar; 69(3):1420-8. PubMed ID: 7531779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody responses to non-immunogenic synthetic peptides induced by co-immunization with immunogenic peptides.
    Partidos CD; Obeid OE; Steward MW
    Immunology; 1992 Oct; 77(2):262-6. PubMed ID: 1385315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human T-lymphotropic virus type 1 peptides in chimeric and multivalent constructs with promiscuous T-cell epitopes enhance immunogenicity and overcome genetic restriction.
    Lairmore MD; DiGeorge AM; Conrad SF; Trevino AV; Lal RB; Kaumaya PT
    J Virol; 1995 Oct; 69(10):6077-89. PubMed ID: 7545241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of a flanking sequence on the immune response to a B and a T cell epitope from the fusion protein of measles virus.
    Partidos CD; Steward MW
    J Gen Virol; 1992 Aug; 73 ( Pt 8)():1987-94. PubMed ID: 1379626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.
    Kaumaya PT; Kobs-Conrad S; Seo YH; Lee H; VanBuskirk AM; Feng N; Sheridan JF; Stevens V
    J Mol Recognit; 1993 Jun; 6(2):81-94. PubMed ID: 7508238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of helper T cell antigenic sites in mice from the haemagglutinin glycoprotein of measles virus.
    Obeid OE; Partidos CD; Steward MW
    J Gen Virol; 1993 Dec; 74 ( Pt 12)():2549-57. PubMed ID: 7506296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hierarchic T-cell help to non-linked B-cell epitopes.
    Brons NH; Blaich A; Wiesmüller KH; Schneider F; Jung G; Muller CP
    Scand J Immunol; 1996 Nov; 44(5):478-84. PubMed ID: 8947599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection against measles virus-induced encephalitis by anti-mimotope antibodies: the role of antibody affinity.
    Olszewska W; Obeid OE; Steward MW
    Virology; 2000 Jun; 272(1):98-105. PubMed ID: 10873752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the antigenic profile of measles virus haemagglutinin in mice and humans using overlapping synthetic peptides.
    Obeid OE; Partidos CD; Steward MW
    Virus Res; 1994 Apr; 32(1):69-84. PubMed ID: 7518172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of the T-helper epitope on the titre and affinity of antibodies to B-cell epitopes after co-immunization.
    Shaw DM; Stanley CM; Partidos CD; Steward MW
    Mol Immunol; 1993 Aug; 30(11):961-8. PubMed ID: 7688851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The molecular basis of virus crossreactivity and neutralisation after immunisation with optimised chimeric peptides mimicking a putative helical epitope of the measles virus hemagglutinin protein.
    El Kasmi KC; Theisen D; Brons NH; Muller CP
    Mol Immunol; 1998 Oct; 35(14-15):905-18. PubMed ID: 9881686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural requirements for synthetic immunogens to induce measles virus specific CTL responses.
    Partidos CD; Delmas A; Steward MW
    Mol Immunol; 1996 Nov; 33(16):1223-9. PubMed ID: 9129158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity of a chimeric peptide corresponding to T helper and B cell epitopes of the Chlamydia trachomatis major outer membrane protein.
    Su H; Caldwell HD
    J Exp Med; 1992 Jan; 175(1):227-35. PubMed ID: 1370528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic immunogens constructed from T-cell and B-cell stimulating peptides (T:B chimeras): preferential stimulation of unique T- and B-cell specificities is influenced by immunogen configuration.
    Levely ME; Mitchell MA; Nicholas JA
    Cell Immunol; 1990 Jan; 125(1):65-78. PubMed ID: 1688404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequential order of T and B cell epitopes affects immunogenicity but not antibody recognition of the B cell epitope.
    Denton G; Hudecz F; Kajtár J; Murray A; Tendler SJ; Price MR
    Pept Res; 1994; 7(5):258-64. PubMed ID: 7531518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of systemic immune responses to measles virus synthetic peptides administered intranasally.
    Hathaway LJ; Partidos CD; Vohra P; Steward MW
    Vaccine; 1995 Nov; 13(16):1495-500. PubMed ID: 8578832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the neutralizing antibody response to the measles virus using synthetic peptides of the haemagglutinin protein.
    Muller CP; Schroeder T; Tu R; Brons NH; Jung G; Schneider F; Wiesmüller KH
    Scand J Immunol; 1993 Nov; 38(5):463-71. PubMed ID: 7694357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.